Bleeding caused by Hemophilia A
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13151 | Anti-inhibitor coagulant complex | A medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B. |
| DB00036 | Coagulation factor VIIa Recombinant Human | A form of recombinant human coagulation Factor VII used to treat hemophilia A and B. |
| DB13923 | Emicizumab | An antibody against Factor IXa and Factor X used to treat hemophilia A. |
| DB13999 | Moroctocog alfa | A recombinant Factor VIII used to treat hemophilia A to control bleeding. |
| DB16007 | Rurioctocog alfa pegol | A pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A. |
| DB09108 | Simoctocog alfa | An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency). |
| DB14738 | Turoctocog alfa pegol | Turoctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to... |
| Drug | Drug Name | Phase | Status | Count |
|---|